BORA PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 791.00 TWD | +1.15% |
|
-1.00% | +5.19% |
Chart calendar Bora Pharmaceuticals Co., LTD.
063969d8110525ec36c39f48e33f3d9.nltnbAggqkd8IH62GHpoJdVL_scM7NKSccqk4dAPtOQ.6QtXBWsRyBcbRxbvXBwjbZkOvbM5pbrmN5_qho9g3qPrPCQLek_yLD9mHQ~5489454605743f03373d90a37b418f6e
Upcoming events on Bora Pharmaceuticals Co., LTD.
Past events on Bora Pharmaceuticals Co., LTD.
| 2025-01-15 20:00 | J.P. Morgan Healthcare Conference |
| 2025-01-09 18:50 | December 2024 Sales and Revenue Release |
| 2024-12-08 19:01 | November 2024 Sales and Revenue Release |
| 2024-11-13 04:23 | Q3 2024 Earnings Release |
| 2024-11-07 19:29 | October 2024 Sales and Revenue Release |
| 2024-10-14 | Extraordinary Shareholders Meeting |
| 2024-10-08 03:30 | September 2024 Sales and Revenue Release |
| 2024-09-18 22:50 | Yuanta Securities Investment Forum |
| 2024-09-08 19:50 | August 2024 Sales and Revenue Release |
| 2024-08-28 02:30 | Taishin Securities Investor Conference |
| 2024-08-13 03:24 | Q2 2024 Earnings Release |
| 2024-08-08 | July 2024 Sales and Revenue Release |
| 2024-06-16 | JP Morgan Investor Conference |
| 2024-06-11 01:30 | June 2024 Sales and Revenue Release |
| 2024-05-26 21:00 | Annual General Meeting |
| 2024-05-19 21:00 | Goldman Sachs TechNet Asia Pacific Conference |
| 2024-05-16 02:00 | Taishin Securities Investor Conference |
| 2024-05-14 04:52 | Q1 2024 Earnings Release |
| 2024-05-08 04:00 | April 2024 Sales and Revenue Release |
| 2024-04-28 | Extraordinary Shareholders Meeting |
Past dividends on Bora Pharmaceuticals Co., LTD.
| 2024-08-11 | Annual 12 TWD |
| 2023-07-05 | Annual 8 TWD |
| 2022-07-06 | Annual 3.5 TWD |
| 2021-09-06 | Annual 2 TWD |
| 2020-07-05 | Annual 2 TWD |
| 2019-07-30 | Annual 3 TWD |
| 2018-07-15 | Annual 0.499519 TWD |
| 2017-07-24 | Annual 0.8 TWD |
| 2016-07-17 | Annual 0.601984 TWD |
| 2015-09-02 | Annual 0.5 TWD |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 4 900 4 900 -0% | 10 494 10 401 0.9% | 14 200 14 195 0.04% | 19 567 | 24 109 | 27 607 |
|
EBITDA Million TWD | Released Forecast Spread | 1 256 1 453 -13.55% | 2 263 2 964 -23.67% | 5 855 5 844 0.2% | 4 605 | 6 346 | 6 152 |
|
EBIT Million TWD | Released Forecast Spread | 1 046 1 056 -0.95% | 1 922 2 404 -20.03% | 5 249 5 373 -2.31% | 4 310 | 6 260 | 7 174 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 1 024 1 034 -0.97% | 1 840 2 543 -27.64% | 4 064 4 268 -4.77% | 5 583 | 7 003 | 6 966 |
|
Net income Million TWD | Released Forecast Spread | 750 755 -0.7% | 1 392 1 803 -22.78% | 3 030 3 121 -2.92% | 4 347 | 5 281 | 5 168 |
|
EPS TWD | Released Forecast Spread | 7,70 7,72 -0.27% | 14,1 18,4 -23.62% | 30,2 31,8 -4.98% | 42,3 | 51,5 | 50,1 |
| Announcement Date | 09/03/22 | 20/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 4 781 4 970 -3.82% | 3 139 3 037 3.33% | 3 075 3 110 -1.1% | 3 206 3 201 0.14% | 2 857 2 857 0.02% | 5 027 4 896 2.69% | 5 615 5 156 8.9% | 5 989 | 5 801 | 6 078 | 6 213 | 6 308 | 5 991 |
|
EBITDA Million TWD | Released Forecast Spread | 1 681 1 515 10.96% | 1 485 1 090 36.2% | 1 370 1 492 -8.2% | 1 320 1 281 3.05% | 1 083 1 293 -16.21% | 994 1 813 -45.16% | 1 473 1 782 -17.33% | 1 763 | |||||
|
EBIT Million TWD | Released Forecast Spread | 1 547 1 460 5.96% | 1 347 1 318 2.22% | 1 219 1 304 -6.51% | 1 320 1 263 4.56% | 892 1 004 -11.11% | 743 1 371 -45.82% | 1 217 1 322 -7.94% | 1 463 | 1 370 | 1 453 | 1 529 | 1 582 | 1 526 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 1 442 1 443 -0.02% | 1 019 1 294 -21.25% | 923 1 031 -10.43% | 680 886 -23.27% | 984 699 40.71% | 1 512 1 235 22.41% | 1 716 1 125 52.61% | 1 364 | 3 590 | 1 272 | 1 381 | 1 458 | 1 496 |
|
Net income Million TWD | Released Forecast Spread | 1 039 1 183 -12.12% | 692 953 -27.38% | 733 659 11.21% | 566 660 -14.3% | 716 511 40.28% | 1 172 930 25.95% | 1 447 812 78.26% | 1 012 | 2 660 | 946 | 1 023 | 1 081 | 1 110 |
|
EPS TWD | Released Forecast Spread | 10,5 12,0 -12.41% | 8,81 9,32 -5.47% | 7,28 6,65 9.54% | 6,09 6,54 -6.92% | 6,88 5,03 36.78% | 11,3 9,19 22.58% | 14,2 8,01 76.76% | 9,84 | 25,8 | 9,17 | 9,93 | 10,5 | 10,8 |
| Announcement Date | 12/05/23 | 14/08/23 | 09/11/23 | 07/03/24 | 14/05/24 | 13/08/24 | 13/11/24 | - | - | - | - | - | - |
More events
Past sector events for Bora Pharmaceuticals Co., LTD.
| Today | AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected) |
| 2025-01-10 07:00 | TILRAY BRANDS, INC.: Q2 2025 Earnings Release |
| 2025-01-10 04:09 | LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release |
| 2025-01-09 18:50 | BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
| 2025-01-09 05:25 | SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release |
| 2025-01-08 | HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release |
| 2025-01-08 03:17 | CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
| 2024-12-10 11:45 | MEDINCELL S.A.: Q2 2025 Earnings Release |
| 2024-12-10 04:02 | LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-10 01:29 | CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6472 Stock
- Calendar Bora Pharmaceuticals Co., LTD.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition